1. Home
  2. CSTE vs CELU Comparison

CSTE vs CELU Comparison

Compare CSTE & CELU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

CSTE

Caesarstone Ltd.

HOLD

Current Price

$1.86

Market Cap

61.9M

Sector

Industrials

ML Signal

HOLD

Logo Celularity Inc.

CELU

Celularity Inc.

HOLD

Current Price

$1.80

Market Cap

56.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CSTE
CELU
Founded
1987
2016
Country
Israel
United States
Employees
N/A
N/A
Industry
Building Materials
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
61.9M
56.7M
IPO Year
2012
N/A

Fundamental Metrics

Financial Performance
Metric
CSTE
CELU
Price
$1.86
$1.80
Analyst Decision
Buy
Strong Buy
Analyst Count
1
1
Target Price
$5.00
$6.00
AVG Volume (30 Days)
536.2K
62.5K
Earning Date
11-12-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$400,656,000.00
$40,578,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$1.59
$76.00
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.86
$1.00
52 Week High
$5.04
$4.35

Technical Indicators

Market Signals
Indicator
CSTE
CELU
Relative Strength Index (RSI) 71.49 44.76
Support Level $0.86 $1.62
Resistance Level $1.94 $2.01
Average True Range (ATR) 0.20 0.12
MACD 0.09 0.01
Stochastic Oscillator 91.73 25.40

Price Performance

Historical Comparison
CSTE
CELU

About CSTE Caesarstone Ltd.

Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).

About CELU Celularity Inc.

Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.

Share on Social Networks: